Treatment of premature labor by prostaglandin synthetase inhibitors
Wiqvist, N.; Kjellmer, I.; Thiringer, K.; Ivarsson, E.; Karlsson, K.
Acta Biologica et Medica Germanica 37(5-6): 923-930
1978
ISSN/ISBN: 0001-5318 PMID: 105528 Document Number: 126919
Document emailed within 1 workday
Related Documents
Buisseret, P.D.; Youlten, L.J.; Heinzelman, D.; Lessof, M.H. 1979: Prostaglandin synthetase inhibitors and food intolerance Monographs in Allergy 14: 197-202Prasad, R.N. 1982: Prostaglandin synthetase inhibitors and their effects on the fetus and the newborn Annals of the Academy of Medicine Singapore 11(4): 513-525
Kuvacić, I.; Skrablin, S.; Drazancić, A.; Fudurić, I.; Hodzić, D. 1990: Peroral and intracervical administration of prostaglandin E2 for stimulation of term labor in premature rupture of fetal membranes Jugoslavenska Ginekologija i Perinatologija 30(5-6): 143-147
Ivanov, S. 1979: Monitor control and the beta-adrenomimetic therapy of premature labor. I. The index of premature labor (IPL) Akusherstvo i Ginekologiia 18(1): 35-37
Lange, A.P.; Secher, N.J.; Nielsen, F.H.; Pedersen, G.T. 1981: Stimulation of labor in cases of premature rupture of the membranes at or near term. a consecutive randomized study of prostaglandin E2-tablets and intravenous oxytocin Acta Obstetricia et Gynecologica Scandinavica 60(2): 207-210
Urade, Y.; Ujihara, M.; Horiguchi, Y.; Ikai, K.; Hayaishi, O. 1989: The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues Journal of Immunology 143(9): 2982-2989
Thoulon, J.M. 1992: What treatment in threatened premature labor? Revue Francaise de Gynecologieet d'Obstetrique 87(7-9): 388391
Cerletti, C.; Chiabrando, C.; Fanelli, R.; de Gaetano, G. 1984: Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis? Lancet 1(8383): 967-968
Tamura, T.; Yoshimura, K. 1982: Premature labor and its management--palliative treatment Nihon Sanka Fujinka Gakkai Zasshi 34(12): 2263-2267
Lembrych, S.; Kuźniar, B. 1984: Dosage of prostaglandin used in labor induced with prostaglandin F2 alpha Ginekologia Polska 55(7): 499-503
Rolland, P.H.; Martin, P.M.; Rolland, A.M.; Bourry, M.; Serment, H. 1979: Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis Obstetrics and Gynecology 54(6): 715-718
Schroder, M.; Peterseim, H.; König, E.; Niedner, W. 1981: Effect of tocolytic treatment on the frequency of premature labor Akusherstvo i Ginekologiia 20(1): 40-42
Kirschbaum, M.; Hermsteiner, M. 1995: Premature rupture of fetal membranes in premature labor. Diagnosis and therapy Der Gynakologe 28(3): 142-152
Lebedeva, I.B. 1984: Effect of preventive administration of glucocorticoids in premature labor on neonatal mortality of premature infants Akusherstvo i Ginekologiia 1984(10): 61-62
Yasunaga, M.; Kato, J. 1983: Introduction do obstetric endocrinology. 7. Methods for treatment of premature labor Josanpu Zasshi 37(10): 855-859
Vangen, O. 1973: Treatment of threatened premature labor. Clinical observations with toxicologic drugs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(12): 850-852
Török, M.; Gáti, I. 1990: The current method of early recognition and treatment of threatened premature labor Orvosi Hetilap 131(14): 731-737
Kuznetsova, N.I. 1987: Informative value of various laboratory indicators for the diagnosis of complications of the suppurative-inflammatory nature of premature labor and premature rupture of fetal membranes Akusherstvo i Ginekologiia 6: 48-50
Ruckhäberle, K.E.; Bilek, K.; Viehweg, B.; Kühndel, K.; Colditz, U.; Bär, G. 1981: The clinical value of radioimmunologic HPL values in the long-term treatment of threatened premature labor Acta Universitatis Palackianae Olomucensis Facultatis Medicae 101: 43-49
Frohlich, E.P. 1988: Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor Obstetrics and Gynecology 71(2): 283